OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 8

Showing 8 citing articles:

Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 1

Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes
Aleksandra Ryk, Anna Marcinkiewicz, Jędrzej Chrzanowski, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Low muscle mass index is associated with type 2 diabetes risk in a Latin-American population: a cross-sectional study
Rosario Suárez, Celina Andrade, Estefanía Bautista-Valarezo, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 4

Empagliflozin Plays Vasoprotective Role in Spontaneously Hypertensive Rats via Activation of the SIRT1/AMPK Pathway
Monika Kloza, Anna Krzyżewska, Hanna Kozłowska, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 507-507
Open Access

Advanced UPLC-Photo Diode Array Method for Precise Quantification of Sotagliflozin in Bulk and Commercial Formulations
B. K. Chatterjee, Prasenjit Mondal, Suman Acharyya
Oriental Journal Of Chemistry (2025) Vol. 41, Iss. 2, pp. 689-696
Open Access

Exploring the Protective Effects of Traditional Antidiabetic Medications and Novel Antihyperglycemic Agents in Diabetic Rodent Models
Cosmin Gabriel Tartau, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tarțău, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 670-670
Open Access

Sodium-glucose co-transporter 2 inhibitors: a pleiotropic drug in humans with promising results in cats
Aline Bomfim Vieira, Sarah M. Cavanaugh, Bianca Torres Ciambarella, et al.
Frontiers in Veterinary Science (2025) Vol. 12
Open Access

HbA1c reduction strategies: An overview of pharmacological interventions
Krishna Upadhye, Hariom Patidar, Narendra Bamnia, et al.
National Journal of Pharmacology and Therapeutics (2025) Vol. 3, Iss. 1, pp. 24-33
Closed Access

Comment on “SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect”
Rose Peronard, Stephan Peronard Mayntz
American Journal of Cardiovascular Drugs (2024)
Closed Access | Times Cited: 1

Psychiatric Disorders and Diabetes: Review of Guidelines for Collaborative Care
Leslie Arceneaux, Karan Kverno
Journal of Psychosocial Nursing and Mental Health Services (2024) Vol. 62, Iss. 9, pp. 7-10
Closed Access

Page 1

Scroll to top